Výsledky vyhledávání - "Erica Hochard"

Evaluation of cytomegalovirus reactivation and tolerability in seropositive umbilical cord transplant patients after implementation of an intensive prevention strategy

Autor: Joseph McGuirk, Erica Hochard, Leyla Shune, Omar S. Aljitawi, Sunil Abhyankar, Tara L. Lin, Michelle Rockey, Siddhartha Ganguly, Anurag Singh, Matthew Rinehart

Publikováno v: Hematology/Oncology and Stem Cell Therapy, Vol 9, Iss 3, Pp 105-111 (2016)

Objective/Background: Cytomegalovirus (CMV) causes significant morbidity and mortality in CMV seropositive patients undergoing umbilical cord blood transplants (UCBT). Our study aimed to describe the incidence of CMV reactivation and burden of diseas

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cae733dd4b2d585384291c899b08c17
http://www.sciencedirect.com/science/article/pii/S165838761630005X

Zobrazit plný text záznamu

27 / Outcomes of VDPACE with Immunomodulator agent as a Salvage therapy for Relapsed/refractory multiple myeloma

Autor: Erica Hochard, Abdallah Al-Ola

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4741ad41e289973342ab0c1fccfaf9d2
https://doi.org/10.26226/morressier.5b3b802db1b87b000eceda16

Zobrazit plný text záznamu

Daratumumab, Pomalidomide, and Dexamethasone (DPd) As Salvage Treatment for Relapsed/Refractory Myeloma Eligible for High-Dose Chemotherapy/Autologous Stem Cell Transplantation

Autor: Ajoy Dias, Erica Hochard, Siddhartha Ganguly, Brian McClune, Joseph P. McGuirk, Al-Ola Abdallah, Zahra Mahmoudjafari, Neil Dunavin, Leyla Shune

Publikováno v: Blood. 132:5760-5760

Introduction: The number of therapeutic options for patients with relapsed refractory multiple myeloma (RRMM) has increased significantly in recent years. There is no standard salvage treatment for these patients who relapse after initial ASCT. Our i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b88d1323da0f3df7966cfae17c607262
https://doi.org/10.1182/blood-2018-99-117654

Zobrazit plný text záznamu

Daratumumab, Pomalidomide, and Dexamethasone (DPd) for the Treatment of Relapsed/Refractory Multiple Myeloma: A Single Institution Experience

Autor: Zahra Mahmoudjafari, Neil Dunavin, Brian McClune, Joseph P. McGuirk, Ajoy Dias, Leyla Shune, Al-Ola Abdallah, Erica Hochard, Siddhartha Ganguly

Publikováno v: Blood. 132:5642-5642

Background: Daratumumab triplet regimens containing dexamethasone and lenalidomide or bortezomib are an effective treatment option for patients with relapsed/refractory multiple myeloma (RRMM). Daratumumab was recently FDA-approved in combination wit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ab3be4b218a7a976a82d256adc460b87
https://doi.org/10.1182/blood-2018-99-117497

Zobrazit plný text záznamu

Outcomes of VDPACE with Immunomodulator Agent as a Salvage Therapy for Relapsed/Refractory Multiple Myeloma

Autor: Al-Ola Abdallah, Leyla Shune, Erica Hochard, Neil Dunavin, Zahra Mahmoudjafar, Siddhartha Ganguly

Publikováno v: Clinical Lymphoma Myeloma and Leukemia. 18:S247

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7a5761a660c8190e8f177e247a5aebca
https://doi.org/10.1016/j.clml.2018.07.145

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání